Kidney Diseases
Pathological processes of the KIDNEY or its component tissues.
Subtype terms (26)
More specific conditions that are subtypes of Kidney Diseases in the MeSH hierarchy.
- AIDS-Associated Nephropathy
5 drugs approved
- Anuria
- Chronic Kidney Disease-Mineral and Bone Disorder
163 drugs (93 approved, 70 experimental)
- Diabetes Insipidus
14 drugs (12 approved, 2 experimental)
- Diabetic Nephropathies
197 drugs (98 approved, 99 experimental)
- Hepatorenal Syndrome
12 drugs (9 approved, 3 experimental)
- Hydronephrosis
5 drugs approved
- Hyperoxaluria
36 drugs (13 approved, 23 experimental)
- Hypertension, Renal
9 drugs (5 approved, 4 experimental)
- Kidney Cortex Necrosis
- Kidney Diseases, Cystic
1 drug approved
- Kidney Neoplasms
338 drugs (164 approved, 174 experimental)
- Kidney Papillary Necrosis
- Nephritis
17 drugs (12 approved, 5 experimental)
- Nephrocalcinosis
3 drugs (2 approved, 1 experimental)
- Nephrolithiasis
60 drugs (42 approved, 18 experimental)
- Nephrosclerosis
1 drug experimental
- Nephrosis
2 drugs (1 approved, 1 experimental)
- Perinephritis
- Renal Artery Obstruction
18 drugs (14 approved, 4 experimental)
- Renal Insufficiency
285 drugs (195 approved, 90 experimental)
- Renal Nutcracker Syndrome
- Renal Tubular Transport, Inborn Errors
- Tuberculosis, Renal
- Uremia
15 drugs (11 approved, 4 experimental)
- Zellweger Syndrome
7 drugs (6 approved, 1 experimental)
Drugs by status
Approved for this indication (22)
- Anti-thymocyte Globulin (Rabbit)
- inulin
- basiliximab
- tacrolimus
- iodohippurate sodium i-131
- losartan
- lymphocyte immune globulin, anti-thymocyte globulin (equine)
- huaiqihuang
- muromonab cd3
- mycophenolate
- sevelamer
- iron dextran
- roxadustat
- yiqitongluo
- kang fu
- desidustat
- colquhounia root
- bumetanide
- alpha-ketoacid
- abelmoschus manihot
- etacrynic acid
- yiqi
Phase 4 trials (133)
- norepinephrine
- gentamicin
- hydroxychloroquine
- sacubitril
- levamisole
- rituximab
- hydrochlorothiazide
- platelet-rich plasma
- simvastatin
- sevoflurane
- folic acid
- citric acid
- hydroxycitrate
- pegmolesatide
- linezolid
- spironolactone
- gadoteric acid
- heparin
- rocuronium
- ropivacaine
- pitavastatin
- cinacalcet
- terlipressin
- dabigatran
- nitroglycerin
- tc-99m-mag3
- diclofenac
- calcium
- hydroxyurea
- menaquinone
- +103 more
Phase 3 trials (93)
- nesiritide
- fenofibrate
- ferric citrate
- volitinib
- telmisartan
- hydrocortisone
- nedosiran
- ketosteril
- fb-lrx
- colistin
- trimethoprim
- immune globulin (human)
- diphenhydramine
- blood plasma
- mil62
- etoposide
- furosemide
- doxorubicin
- mb-102
- prednisolone
- white wine
- mor202
- nitrofurantoin
- nivolumab
- xenon xe-133
- obinutuzumab
- irbesartan
- procaine benzylpenicillin
- ramipril
- dasabuvir
- +63 more
Phase 2 trials (132)
- zarnestra
- allogeneic adipose derived mesenchymal stem cell
- nicotinamide
- rmc-035
- sg301
- colchicine
- ibutamoren
- naproxen
- ganciclovir
- nystatin
- resomelagon
- l-glutamine
- bremelanotide
- thiamine
- lenvatinib
- bone marrow derived mesenchymal stem cells
- ferumoxytol
- COVID-19 convalescent plasma
- mze829
- gusperimus
- Posoleucel
- sasanlimab
- lumasiran
- ro4929097
- lanraplenib
- axitinib
- hsk39297
- shr-2010
- ily101
- lenalidomide
- +102 more
Phase 1 trials (102)
- avibactam
- elafibranor
- eprosartan
- oblimersen sodium
- oxaliplatin
- yk012
- lofexidine
- isavuconazonium
- gsk4771261
- spi-62
- cefepime
- ranolazine
- edg-7500
- aldafermin
- anx-042
- telavancin
- ceftaroline fosamil
- soybean oil
- zidovudine
- prostate specific membrane antigen
- ds-1093
- iobitridol
- sibeprenlimab
- Enmetazobactam
- human fecal microbiota
- Mirodenafil
- Leritrelvir
- ulipristal
- cxa-10
- n-acetylmannosamine
- +72 more
Other trials (63)
- faricimab
- oxybutynin
- red blood cells
- Bacterial Lysates
- pioglitazone
- desflurane
- mizoribine
- acetylsalicylic acid
- magnesium
- amniotic fluid
- leflunomide
- glucagon
- water
- kremezin
- fatty acid
- methocarbamol
- 51cr-edta
- ulinastatin
- dexamethasone
- Lactobacillus acidophilus
- perflutren protein-type a microspheres
- epinephrine
- aflibercept
- glucose
- bifidobacterium longum
- bifidobacterium bifidum
- betamethasone
- technetium tc-99m sestamibi
- 99mtc-dtpa
- apple
- +33 more
Organizations
Organization Involved with Phase 4 Indications (322)
- Hospital General de México Dr. Eduardo Liceaga
- Showa University
- University of Cincinnati
- Gachon University
- Harvard University
- Oregon Health and Science University
- University of Montreal
- State University of New York, Brooklyn
- Gilead Sciences
- Coney Island Hospital, Brooklyn, NY
- Fundación Renal Iñigo Alvarez De Toledo
- Ural Institute of Cardiology
- Veloxis Pharmaceuticals
- University of Southern Denmark
- Kyushu University
- Ironwood Pharmaceuticals
- University of Kansas
- Shin Kong Wu Ho-Su Memorial Hospital
- University of London
- Azienda Sanitaria Ospedaliera
- Chinese University of Hong Kong
- Aristotle University of Thessaloniki
- Instituto Dante Pazzanese de Cardiologia
- University of New South Wales
- Sociedad Andaluza de Trasplantes de Organos y Tejidos
- Kyung Hee University
- Assiut University
- Tsinghua University
- Saglik Bilimleri Universitesi
- University of Roma La Sapienza
- +292 more
Organization Involved with Phase 3 Indications (233)
- Kyowa Hakko Kirin
- Moorgreen Hospital, Southampton
- East Kent Hospitals University NHS Foundation Trust
- Pamlab
- Hospira
- Badalona Hospital Germans Trias i Pujol
- University of Barcelona
- Ipsen
- University of California, Los Angeles
- Anglia Ruskin University
- Cadila Healthcare
- Ajou University
- Department of Defense
- Opko
- Scios
- Baskent University
- Idorsia Pharmaceuticals Ltd.
- Hannover Clinical Trial Center GmbH
- Tricida, Inc.
- Bellus Health Inc
- Hospital general Universitario de Ciudad Real
- Hallym University
- Chongqing Medical University
- Fuji Yakuhin Co., Ltd.
- Sanofi
- Government of Singapore
- University of Washington
- Al Azhar University
- IL Sogno di Stefano
- Unidad de Investigacion Medica en Enfermedades Renales
- +203 more
Organization Involved with Phase 2 Indications (169)
- University of Pisa
- Katholieke Universiteit Leuven
- German Federal Ministry of Education and Research
- CytoPherx
- Government of Taiwan
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Al-Ahliyya Amman University
- Augusta University
- Ionis Pharmaceuticals, Inc.
- University of Applied Sciences Würzburg-Schweinfurt
- Osakidetza
- A2 Healthcare Taiwan Corporation
- SynAct Pharma Aps
- Government of Netherlands
- Shiraz University
- Dimerix Bioscience Pty Ltd
- Cell Therapy And Technology, S.a. De C.v.
- LCR Clinical Research
- Centocor
- Angelini
- Pharmaterra
- Shenzhen University
- CTI Clinical Trial and Consulting Services
- Novelion Therapeutics
- South Texas Health Care System, San Antonio, TX
- Alexion
- Upjohn
- PhytoHealth Corporation
- Institute of Clinical and Experimental Medicine Nephrology Clinic Prague
- Tulane University
- +139 more
Organization Involved with Phase 1 Indications (60)
- Medicine Zibo Wanjie Tumor Hospital
- FerruMax Pharmaceuticals, Inc.
- Baishi Hospital
- Conatus Pharmaceuticals
- Guangzhou Pharmaceucal Company Limited
- Zouping Country Hospital of Traditional Chinese Medicine
- GNI Group
- Hengrui Therapeutics, Inc.
- She Country Hospital of Traditional Chinese Medicine
- Royan Institute
- Savient Pharmaceuticals
- Georgetown University
- Mazandaran University of Medical Sciences
- Baodin City Hospital of Traditional Chinese Medicine
- Harbin Medical University
- Medivation
- MannKind Corp
- Vidasym, Inc.
- Taisho Pharmaceutical
- National Research Council, Brazil
- Kunming Medical University
- Genfit
- University of Thessaly
- Federal University of Rio de Janeiro
- Aduro BioTech
- Pharmaceutical Research Associates, Inc. (PRA)
- Aperion Biologics
- Chelsea Therapeutics
- Government of Brazil
- ClinSmart
- +30 more
Organization Involved with Other Experimental Indications (98)
- Nagahama City Hospital
- Kaohsiung Medical University
- Alberta Heritage Foundation for Medical Research
- University of Eastern Piedmont
- Danish Heart Foundation
- Dialysis Clinic, Inc.
- Kanazawa University
- Kidney Cancer UK
- Tomita Clinic
- University of Connecticut
- Nicolaus Copernicus University
- Worldwide Clinical Trials
- Ako City Hospital
- Medical University of South Carolina
- Zagazig University
- Horide Clinic
- University of Oklahoma
- Technical University of Dresden
- Centro Universitário Univates
- NTT West Osaka Hospital
- "Maggiore della Carità" Hospital
- Wayne State University
- Shaheed Faghihi Hospital
- Omihachiman COmmunity Medical Center
- Nazareth EMMS Hospital
- Tzu Chi University
- FlowMedic
- Shiga Clinic
- Toyosato Hospital
- University of Illinois
- +68 more